Team:Gothenburg-Sweden/Project/more
From 2010.igem.org
Line 59: | Line 59: | ||
padding-left: 10px; | padding-left: 10px; | ||
list-style: none; | list-style: none; | ||
- | line-height: | + | line-height: 18.3px; |
text-transform: uppercase; | text-transform: uppercase; | ||
font-family: Arial, Helvetica, sans-serif; | font-family: Arial, Helvetica, sans-serif; | ||
Line 187: | Line 187: | ||
- | <table width=" | + | <table width="727" border="0" align="center" cellpadding="0" cellspacing="0"> |
<tr valign="top"> | <tr valign="top"> | ||
<td width="429"><img src="https://static.igem.org/mediawiki/2010/9/98/1-1.jpg" alt="" width="429" height="302" /></td> | <td width="429"><img src="https://static.igem.org/mediawiki/2010/9/98/1-1.jpg" alt="" width="429" height="302" /></td> | ||
- | <td><table width="99%" border="0" cellspacing="0" cellpadding="0"> | + | <td width="298"><table width="99%" border="0" cellspacing="0" cellpadding="0"> |
<tr> | <tr> | ||
<td class="bg3"><table width="260" border="0" align="center" cellpadding="0" cellspacing="0"> | <td class="bg3"><table width="260" border="0" align="center" cellpadding="0" cellspacing="0"> | ||
Line 198: | Line 198: | ||
<tr> | <tr> | ||
<td class="bg1"><table width="250" border="0" align="center" cellpadding="0" cellspacing="0"> | <td class="bg1"><table width="250" border="0" align="center" cellpadding="0" cellspacing="0"> | ||
- | + | <tr> | |
- | + | <td width="301" height="203"><ul class="list1"> | |
- | + | ||
- | + | ||
- | <td width="301"><ul class="list1"> | + | |
<li><a href="https://2010.igem.org/Team:Gothenburg-Sweden/Project">Project</a></li> | <li><a href="https://2010.igem.org/Team:Gothenburg-Sweden/Project">Project</a></li> | ||
<li><a href="https://2010.igem.org/Team:Gothenburg-Sweden/Lab_Note">Lab Note </a></li> | <li><a href="https://2010.igem.org/Team:Gothenburg-Sweden/Lab_Note">Lab Note </a></li> | ||
<li><a href="https://2010.igem.org/Team:Gothenburg-Sweden/Results">Results</a></li> | <li><a href="https://2010.igem.org/Team:Gothenburg-Sweden/Results">Results</a></li> | ||
<li><a href="https://2010.igem.org/Team:Gothenburg-Sweden/About_us">About Us</a></li> | <li><a href="https://2010.igem.org/Team:Gothenburg-Sweden/About_us">About Us</a></li> | ||
+ | <li><a href="https://2010.igem.org/Team:Gothenburg-Sweden/Sponsors">Sponsors</a></li> | ||
<li><a href="https://2010.igem.org/Team:Gothenburg-Sweden/Contact">Contact Us</a></li> | <li><a href="https://2010.igem.org/Team:Gothenburg-Sweden/Contact">Contact Us</a></li> | ||
- | + | </ul></td> | |
- | + | </tr> | |
- | + | </table></td> | |
</tr> | </tr> | ||
- | + | </table></td> | |
</tr> | </tr> | ||
</table> | </table> | ||
Line 219: | Line 217: | ||
<td width="725",border="0" cellspacing="0" cellpadding="0"> | <td width="725",border="0" cellspacing="0" cellpadding="0"> | ||
- | + | <tr> | |
<td><img src="https://static.igem.org/mediawiki/2010/2/23/Spacer.jpg" alt="" width="30" height="30" /></td> | <td><img src="https://static.igem.org/mediawiki/2010/2/23/Spacer.jpg" alt="" width="30" height="30" /></td> | ||
- | + | </tr> | |
<tr> | <tr> | ||
<td><span class="text1">project description </span></td> | <td><span class="text1">project description </span></td> | ||
Line 317: | Line 315: | ||
<p><br> | <p><br> | ||
To reach the project goal several procedures need to be performed. Firstly the most suitable positions of the fluorescent proteins need to be determined. This will be done by studying parts of the crystal structure of the protein complex. The distances between the fluorophores are measured to secure that they are optimal with respect to the intrinsic properties of the flurophore pair. After this the fusion protein genome will be synthesized through fusion PCR. The fusion protein genome is then inserted into the yeast plasmid pSGM1 with the aid of several restriction endonucelases. The plasmids will be amplified in <em>E. coli</em> after which they are sent to be sequenced to make sure that the correct insert has been created. The last step is to transform a yeast strain with the plasmids, expose the cells to different stress factors and study the FRET signal. The FRET-signal will be used to quantify the expression level of the SNF1 complex.<br> | To reach the project goal several procedures need to be performed. Firstly the most suitable positions of the fluorescent proteins need to be determined. This will be done by studying parts of the crystal structure of the protein complex. The distances between the fluorophores are measured to secure that they are optimal with respect to the intrinsic properties of the flurophore pair. After this the fusion protein genome will be synthesized through fusion PCR. The fusion protein genome is then inserted into the yeast plasmid pSGM1 with the aid of several restriction endonucelases. The plasmids will be amplified in <em>E. coli</em> after which they are sent to be sequenced to make sure that the correct insert has been created. The last step is to transform a yeast strain with the plasmids, expose the cells to different stress factors and study the FRET signal. The FRET-signal will be used to quantify the expression level of the SNF1 complex.<br> | ||
- | + | </p> | |
<p>A secondary task is to measure the expression levels of the SNF1 complex through western blot with probes that only bind to the phosphorylated (active) protein. These levels will be compared to the expression levels derived through the FRET-analysis. Our expectation is to find a linear correlation between both measurements.</p> | <p>A secondary task is to measure the expression levels of the SNF1 complex through western blot with probes that only bind to the phosphorylated (active) protein. These levels will be compared to the expression levels derived through the FRET-analysis. Our expectation is to find a linear correlation between both measurements.</p> | ||
The long term ambition of this project it is to ultimately use the results in the pharmaceutical industry when performing high-throughput screening for new substances or finding the correct drug concentrations to use. The yeast cells with the modified SNF-complex can be moved through a micro-fluidic system, gradually exposing them to an array of substances or a concentration gradient and easily finding out at which concentration or substance that the cells are stressed.</td> | The long term ambition of this project it is to ultimately use the results in the pharmaceutical industry when performing high-throughput screening for new substances or finding the correct drug concentrations to use. The yeast cells with the modified SNF-complex can be moved through a micro-fluidic system, gradually exposing them to an array of substances or a concentration gradient and easily finding out at which concentration or substance that the cells are stressed.</td> | ||
Line 353: | Line 351: | ||
4: Two fragments with homology are run together, resulting in fusion and amplification. <br> | 4: Two fragments with homology are run together, resulting in fusion and amplification. <br> | ||
5: The product from step 4 is run with the last homology fragment, resulting in fusion and amplification of the final product. </span><br> | 5: The product from step 4 is run with the last homology fragment, resulting in fusion and amplification of the final product. </span><br> | ||
- | + | </p> | |
<p>References:</p> | <p>References:</p> | ||
<ul> | <ul> | ||
Line 366: | Line 364: | ||
<p><br> | <p><br> | ||
<img src="https://static.igem.org/mediawiki/2010/a/a8/Project_clip_image002.gif" alt="FRET1" width="102" height="48"> eq 1 <br> | <img src="https://static.igem.org/mediawiki/2010/a/a8/Project_clip_image002.gif" alt="FRET1" width="102" height="48"> eq 1 <br> | ||
- | + | </p> | |
<p>In equation 1, τD is the lifetime of the donor in the absence of acceptor and r is the donor to acceptor distance. The distance at which the resonance energy transfer efficiency is 50 % is called the Förster distance, R0. At this distance, half of the donor molecules are decaying by energy transfer and half are decaying by the radiative and non-radiative rates. This distance is typically in the rage of 20 to 60 Å. The energy transfer efficiency (E) is the fraction of energy absorbed by the donor which is transferred to the acceptor. This fraction is given by equation 2.</p> | <p>In equation 1, τD is the lifetime of the donor in the absence of acceptor and r is the donor to acceptor distance. The distance at which the resonance energy transfer efficiency is 50 % is called the Förster distance, R0. At this distance, half of the donor molecules are decaying by energy transfer and half are decaying by the radiative and non-radiative rates. This distance is typically in the rage of 20 to 60 Å. The energy transfer efficiency (E) is the fraction of energy absorbed by the donor which is transferred to the acceptor. This fraction is given by equation 2.</p> | ||
<p><br> | <p><br> | ||
<img src="https://static.igem.org/mediawiki/2010/1/1a/Project_clip_image004.gif" alt="FRET2" width="81" height="48"> eq 2 <br> | <img src="https://static.igem.org/mediawiki/2010/1/1a/Project_clip_image004.gif" alt="FRET2" width="81" height="48"> eq 2 <br> | ||
- | + | </p> | |
<p>Combining these two equations gives an expression for how the energy transfer efficiency varies as the inverse sixth power of the distance between the donor and acceptor molecules, equation 3 (Lakowicz, 2006).</p> | <p>Combining these two equations gives an expression for how the energy transfer efficiency varies as the inverse sixth power of the distance between the donor and acceptor molecules, equation 3 (Lakowicz, 2006).</p> | ||
<p><br> | <p><br> | ||
<img src="https://static.igem.org/mediawiki/2010/d/d5/Project_clip_image006.gif" alt="FRET3" width="76" height="48"> eq 3 <br> | <img src="https://static.igem.org/mediawiki/2010/d/d5/Project_clip_image006.gif" alt="FRET3" width="76" height="48"> eq 3 <br> | ||
- | + | </p> | |
<p>The expression is graphically demonstrated in figure 3. Because of the inverse sixth power dependence on the distance between the donor and acceptor molecule, the curve has a very sharp decline. When designing a biochemical experiment the distance between the donor and acceptor molecule is of great importance. The useful range for measuring FRET is between 0.5 times R0 and 1.5 times R0. For most applications in cell biology, FRET experiments have a relatively binary readout. Measurements will often only be able to distinguish between high-FRET and low-FRET, or simply between the presence and absence of FRET (Kremers, Piston and Davidson, n.d.).</p> | <p>The expression is graphically demonstrated in figure 3. Because of the inverse sixth power dependence on the distance between the donor and acceptor molecule, the curve has a very sharp decline. When designing a biochemical experiment the distance between the donor and acceptor molecule is of great importance. The useful range for measuring FRET is between 0.5 times R0 and 1.5 times R0. For most applications in cell biology, FRET experiments have a relatively binary readout. Measurements will often only be able to distinguish between high-FRET and low-FRET, or simply between the presence and absence of FRET (Kremers, Piston and Davidson, n.d.).</p> | ||
<p> </p> | <p> </p> | ||
Line 383: | Line 381: | ||
<ul> | <ul> | ||
<li>Kremers, G.-J., Piston, D.W. and Davidson, M.W. <em>Microscopyu</em>, [Online], Available: <a href="http://www.microscopyu.com/articles/fluorescence/fret/fretintro.html">http://www.microscopyu.com/articles/fluorescence/fret/fretintro.html</a> [09 Jul 2010].<br> | <li>Kremers, G.-J., Piston, D.W. and Davidson, M.W. <em>Microscopyu</em>, [Online], Available: <a href="http://www.microscopyu.com/articles/fluorescence/fret/fretintro.html">http://www.microscopyu.com/articles/fluorescence/fret/fretintro.html</a> [09 Jul 2010].<br> | ||
- | + | </li> | |
<li>Lakowicz, J.R. (2006) <em>Principles of Fluorescence Spectroscopy</em>, Third edition edition, New York: Springer.</li> | <li>Lakowicz, J.R. (2006) <em>Principles of Fluorescence Spectroscopy</em>, Third edition edition, New York: Springer.</li> | ||
</ul> <p> </p></td> | </ul> <p> </p></td> | ||
Line 433: | Line 431: | ||
<ul> | <ul> | ||
<li> Carlson, M., Osmond, B. C., Botstein, D. (1981) Mutants of yeast defective in sucrose utilization. <em>Genetics, </em>98:25-40.<br> | <li> Carlson, M., Osmond, B. C., Botstein, D. (1981) Mutants of yeast defective in sucrose utilization. <em>Genetics, </em>98:25-40.<br> | ||
- | + | </li> | |
<li>Celenza, J. L., Carson, M. (1989) Mutational Analysis of the Saccharomyces cerevisiae SNF1 Protein<br> | <li>Celenza, J. L., Carson, M. (1989) Mutational Analysis of the Saccharomyces cerevisiae SNF1 Protein<br> | ||
Kinase and Evidence for Functional Interaction with the SNF4 Protein. <em>Molecular and cellular biology </em>9: 5034-5044</li> | Kinase and Evidence for Functional Interaction with the SNF4 Protein. <em>Molecular and cellular biology </em>9: 5034-5044</li> | ||
Line 445: | Line 443: | ||
</li> | </li> | ||
<li>McCartney, R. R , Schmidt, C. S. (2001) Regulation of Snf1 Kinase Activation requires phosphorylation of threonine 210 by an upstream kinase as well as a distinct step mediated by the Snf4 subunit<strong>. </strong><em>The Journal of Biological Chemistry, </em>276:36460-36466<br> | <li>McCartney, R. R , Schmidt, C. S. (2001) Regulation of Snf1 Kinase Activation requires phosphorylation of threonine 210 by an upstream kinase as well as a distinct step mediated by the Snf4 subunit<strong>. </strong><em>The Journal of Biological Chemistry, </em>276:36460-36466<br> | ||
- | + | </li> | |
<li><strong>Vincent, O., Townley, R., Kuchin, S. and Carlson, M. (2001)</strong> Subcellular localization of the Snf1 kinase is regulated by specific β subunits and a novel glucose signaling mechanism. <em>Genes and Development </em>15; 1104-1114<br> | <li><strong>Vincent, O., Townley, R., Kuchin, S. and Carlson, M. (2001)</strong> Subcellular localization of the Snf1 kinase is regulated by specific β subunits and a novel glucose signaling mechanism. <em>Genes and Development </em>15; 1104-1114<br> | ||
- | + | </li> | |
<li><strong>Wiatrowski, H. A., van Denderen, B. J. W, Berkey, C. D., Kemp, B. E., Stapleton, D. and Carlson, M. (2004) </strong>Mutations in the Gal83 Glycogen-Binding Domain Activate the Snf1/Gal83 Kinase Pathway by a Glycogen-Independent Mechanism. <em>Molecular and Cellular Biology</em> 24; 352-361</li> | <li><strong>Wiatrowski, H. A., van Denderen, B. J. W, Berkey, C. D., Kemp, B. E., Stapleton, D. and Carlson, M. (2004) </strong>Mutations in the Gal83 Glycogen-Binding Domain Activate the Snf1/Gal83 Kinase Pathway by a Glycogen-Independent Mechanism. <em>Molecular and Cellular Biology</em> 24; 352-361</li> | ||
</ul> | </ul> |
Revision as of 12:55, 14 July 2010
project description | |||||||||||||||||||||||||||||
More about the project | |||||||||||||||||||||||||||||
Aim | |||||||||||||||||||||||||||||
The aim of the project is to present a contribution to the IGEM competition in synthetic biology. The project consists of creating a sensor for cellular stress readouts. The organism of choice is yeast and the protein that is used to study the phenomena is SNF1. Our contribution to the IGEM competition in synthetic biology consists of creating a sensor for cellular stress readouts. The organism of choice is yeast and the protein that is used to study the phenomena is SNF1 which is a kinase that is activated when the cells are stressed. |
|||||||||||||||||||||||||||||
theoretic background | |||||||||||||||||||||||||||||
The cellular stress is sensed by a key protein called AMP-activated protein kinase (AMPK). The AMPK protein complex is conserved among all eukaryotes, including yeast, plants and humans. In humans this is the target of most anti-diabetic drugs in the market today and is also implicated in many other metabolic disorders such as obesity and atherosclerosis and also in developmental processes such as cell cycle and ageing, etc. In yeast, this protein is called SNF1. This protein functions as a heterotrimer consisting of α, β and γ subunits. The α-subunit contains the catalytic domain (actual kinase) while the β-subunit is the regulatory domain. It response to high levels of AMP and undergoes a conformational change, which exposes the phosphorylation site on the catalytic α-subunit. AMPK is activated by phosphorylation on this conserved site on the α-subunit (shown in the figure below).
Figure 1: (1)Structure of the AMPK heterotrimer. The figure on the left shows the conformation in an inactive state. On the right, the conformational change in the γ-subunit triggers a structural change in the α-subunit, which is phosphorylated. (2) Schematic representation (stereo view) of the heterotrimer core of SNF1. The regulatory sequence of the a-subunit (Snf1) is shown in red and the rest is in yellow; theGBDof the b-subunit (Sip2) is shown in cyan and the rest is in magenta; and the c-subunit (Snf4) is shown in green. The positions of AMP (stick model in black), as observed from our studies and in the S. pombe enzyme9, as well as that of b-cyclodextrin (in grey) as bound in the rat GBD10, are shown for reference.
The conceptual idea is to use the conformational change in the Snf1 complex to establish a FRET (Förster Resonance Energy Transfer) system. There are two chromophores tagged at appropriate locations. Upon undergoing the conformational change, they come in close proximity such that the emission energy from one can excite the other, thus resulting in different emission energy. There are two possibilities to be tested. |
|||||||||||||||||||||||||||||
method and execution | |||||||||||||||||||||||||||||
|
Home | About us | Chalmers | Sponsors | Contact Us |
Design in Chalmers, Gothenburg, Sweden |